1. Home
  2. ITCI vs AUR Comparison

ITCI vs AUR Comparison

Compare ITCI & AUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • AUR
  • Stock Information
  • Founded
  • ITCI 2002
  • AUR 2017
  • Country
  • ITCI United States
  • AUR United States
  • Employees
  • ITCI N/A
  • AUR N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • AUR EDP Services
  • Sector
  • ITCI Health Care
  • AUR Technology
  • Exchange
  • ITCI Nasdaq
  • AUR Nasdaq
  • Market Cap
  • ITCI 8.0B
  • AUR 9.6B
  • IPO Year
  • ITCI N/A
  • AUR N/A
  • Fundamental
  • Price
  • ITCI $84.69
  • AUR $6.05
  • Analyst Decision
  • ITCI Strong Buy
  • AUR Hold
  • Analyst Count
  • ITCI 12
  • AUR 4
  • Target Price
  • ITCI $97.67
  • AUR $4.63
  • AVG Volume (30 Days)
  • ITCI 747.9K
  • AUR 12.3M
  • Earning Date
  • ITCI 10-30-2024
  • AUR 10-30-2024
  • Dividend Yield
  • ITCI N/A
  • AUR N/A
  • EPS Growth
  • ITCI N/A
  • AUR N/A
  • EPS
  • ITCI N/A
  • AUR N/A
  • Revenue
  • ITCI $613,728,000.00
  • AUR N/A
  • Revenue This Year
  • ITCI $48.25
  • AUR N/A
  • Revenue Next Year
  • ITCI $38.47
  • AUR $1,736.18
  • P/E Ratio
  • ITCI N/A
  • AUR N/A
  • Revenue Growth
  • ITCI 46.08
  • AUR N/A
  • 52 Week Low
  • ITCI $58.14
  • AUR $2.06
  • 52 Week High
  • ITCI $93.45
  • AUR $7.01
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 55.47
  • AUR 53.76
  • Support Level
  • ITCI $81.83
  • AUR $5.66
  • Resistance Level
  • ITCI $86.36
  • AUR $6.48
  • Average True Range (ATR)
  • ITCI 2.47
  • AUR 0.48
  • MACD
  • ITCI -0.76
  • AUR 0.04
  • Stochastic Oscillator
  • ITCI 30.64
  • AUR 69.64

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About AUR Aurora Innovation Inc.

Aurora Innovation Inc is engaged in delivering self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles, and underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, an advanced and scalable suite of self-driving hardware, software and data services designed as a platform to adapt and interoperate amongst vehicle types and applications.

Share on Social Networks: